GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » MedTech Acquisition Corp (NAS:MTACU) » Definitions » Price-to-Owner-Earnings

MedTech Acquisition (MedTech Acquisition) Price-to-Owner-Earnings : (As of Jun. 09, 2024)


View and export this data going back to 2020. Start your Free Trial

What is MedTech Acquisition Price-to-Owner-Earnings?

As of today (2024-06-09), MedTech Acquisition's share price is $11.35. MedTech Acquisition does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for MedTech Acquisition's Price-to-Owner-Earnings or its related term are showing as below:


MTACU's Price-to-Owner-Earnings is not ranked *
in the Diversified Financial Services industry.
Industry Median: 6.27
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-09), MedTech Acquisition's share price is $11.35. MedTech Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00. Therefore, MedTech Acquisition's PE Ratio for today is N/A.

As of today (2024-06-09), MedTech Acquisition's share price is $11.35. MedTech Acquisition's EPS without NRI for the trailing twelve months (TTM) ended in was $0.00. Therefore, MedTech Acquisition's PE Ratio without NRI for today is N/A.

During the past 3 years, MedTech Acquisition's highest PE Ratio without NRI was 201.89. The lowest was 0.00. And the median was 0.00.


MedTech Acquisition Price-to-Owner-Earnings Historical Data

The historical data trend for MedTech Acquisition's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedTech Acquisition Price-to-Owner-Earnings Chart

MedTech Acquisition Annual Data
Trend Dec20 Dec21 Dec22
Price-to-Owner-Earnings
- - -

MedTech Acquisition Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MedTech Acquisition's Price-to-Owner-Earnings

For the Shell Companies subindustry, MedTech Acquisition's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedTech Acquisition's Price-to-Owner-Earnings Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, MedTech Acquisition's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where MedTech Acquisition's Price-to-Owner-Earnings falls into.



MedTech Acquisition Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

MedTech Acquisition's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=11.35/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedTech Acquisition  (NAS:MTACU) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


MedTech Acquisition Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of MedTech Acquisition's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


MedTech Acquisition (MedTech Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
48 Maple Avenue, Greenwich, CT, USA, 06830
Website
MedTech Acquisition Corp is a blank check company.
Executives
Magnetar Financial Llc 10 percent owner 1603 ORRINGTON AVE., 13TH FLOOR, EVANSTON IL 60201
Magnetar Capital Partners Lp 10 percent owner 1603 ORRINGTON AVE., 13TH FLOOR, EVANSTON IL 60201
Supernova Management Llc 10 percent owner 1603 ORRINGTON AVENUE, 13TH FLOOR, EVANSTON IL 60201
David J. Snyderman 10 percent owner C/O MAGNETAR FINANCIAL LLC, 1603 ORRINGTON AVENUE, 13TH FLOOR, EVANSTON IL 60201
David L Treadwell director 222 S 15TH STREET, SUITE 600 N, OMAHA NE 68102
Manuel Aguero director 600 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10022
Thierry B. Thaure director 3957 POINT EDEN WAY, HAYWARD CA 94545
David J Matlin director, 10 percent owner, officer: Chief Financial Officer
Karim Karti director C/O IRHYTHM TECHNOLOGIES, INC., 650 TOWNSEND STREET, SUITE 500, SAN FRANCISCO CA 94103
Christopher C Dewey director, 10 percent owner, officer: Chief Executive Officer 120 BROADWAY, 27TH FLOOR, NEW YORK NY 10271
Robert H. Weiss officer: Chief Admin Officer and Sec. 585 WEED STREET, NEW CANAAN CT 06840
Maurice R Ferre director C/O MAKO SURGICAL CORP., 2555 DAVIE ROAD, FORT LAUDERDALE FL 33317
Ivan Delevic director C/O MAKO SURGICAL CORP., 2555 DAVIE ROAD, SUITE 110, FORT LAUDERDALE FL 33317
Medtech Acquisition Sponsor Llc 10 percent owner 1345 AVENUE OF THE AMERICAS, NEW YORK NY 10105
Martin William Roche director 600 FIFTH AVENUE, 22ND FLOOR, NEW YORK NY 10022

MedTech Acquisition (MedTech Acquisition) Headlines

From GuruFocus